Becton Dickinson's glucose tests cleared for additional test sites:
This article was originally published in Clinica
Becton Dickinson has gained US go-ahead to expand the number of sites on the body on which it can use its blood glucose monitors - the BD logic and the Paradigm Link. Previously the products were only recommended for fingertip testing, however, repetitive injection can often make the site uncomfortable and inconvenient. The device can now be used on the palm and forearm. The Franklin Lakes, New Jersey company says that while other meters on the market have been cleared for alternate site testing, BD is now one of only a few that can claim that palm testing is equivalent to fingertip testing for blood glucose monitoring systems.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.